US President Trump announced plans to raise pharmaceutical import tariffs from a “small” initial rate to 150 per cent, and eventually 250 per cent, aiming to boost domestic production within 18 months ...

Rigel (RIGL) delivered earnings and revenue surprises of +66.50% and +28.99%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

The Trump administration says it's aiming to lower drug costs for Americans. It's given drug companies 60 days to lower ...

President Donald Trump said on Tuesday that the United States would initially place a "small tariff" on pharmaceutical ...

Marta Wosińska, Senior Fellow at the Center on Health Policy at the Brookings Institution, discusses President Trump ...

Holivita from Holiverse uses blockchain-secured data to give users control, enabling personalized preventive healthcare and ...

Pfizer beats Q2 2025 estimates, raises EPS guidance, boasts a 7%+ dividend yield, yet faces patent and pricing risks. See why ...

Bourla, who took over as CEO in 2019, has declined to say how long he intends to remain in his role at Pfizer. Developing a ...

Millions of people are alive today because of leukemia therapies that arose from UC research, including retired Army Major ...

President Donald Trump threatened to levy tariffs of up to 250% on pharmaceuticals imported into the United States.

Welcome to Contract Pharma’s annual ranking of the Top 20 Pharma and Biopharma Companies, based on fiscal year 2024 ...

Trump’s drug and chip tariffs could reshape supply chains before they launch. Here’s how escalating rates and hidden costs ...